Fig. 1From: Blood pressure control in type 2 diabetic patientsBeneficial effects of SGLT2 inhibitors, SNS, sympathetic nervous system; LDL-c, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterolBack to article page
